Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
104.52
-0.22 (-0.21%)
Sep 2, 2026, 10:52 AM EDT - Market open
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $7.2 billion as of September 2, 2026. Its market cap has increased by 5.04% in one year.
Market Cap
7.20B
Enterprise Value
6.98B
1-Year Change
5.04%
Ranking
Category
Stock Price
$104.52
ChartMarket Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $7.20B, an increase of 784.19%. That is a compound annual growth rate of 27.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 7.20B | 0.74% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunovant | 8.47B |
| ImmunityBio | 8.37B |
| Spyre Therapeutics | 7.75B |
| TG Therapeutics | 7.60B |
| Caris Life Sciences | 7.03B |
| Scholar Rock Holding | 6.99B |
| CG Oncology | 6.47B |
| Mirum Pharmaceuticals | 6.23B |